Posts Tagged ‘OHSU Knight Cancer Institute’

Nobel Laureate David Baltimore to speak at OHSU this Friday, Sept. 20

The Research in Progress Seminar Series (RIPSS) invites you to attend this special talk featuring Nobel Laureate David Baltimore, Ph.D., Millikan Professor of Biology, California Institute of Technology. Dr. Baltimore will discuss strategies in “Preventing the Spread of HIV by Programing Muscle Cells to Make Broadly Neutralizing Antibodies.” The seminar will take place at 9 a.m. on Friday, September 20 in the OHSU Old Library Auditorium. About Dr. Baltimore David Baltimore is an American biologist, … Read More

October Basic & Translation Sciences Seminar Series schedule

The Basic & Translational Sciences Seminar Series, co-sponsored by the Knight Cancer Institute and the Department of Cell & Developmental Biology, provides an emphasis on fundamental science and translational research topics presented by leading extramural scientists. Upcoming speakers in October: October 7 at 4 p.m. in Vollum room M1441 – Mark LaBarge, Ph.D., Lawrence Berkeley National Laboratory October 14 at 4 p.m. in Richard Jones Hall room 4320  – David Cheresh, Ph.D., University of California, … Read More

Knight Cancer and Cell & Developmental Biology seminar series merge

The Knight Cancer Institute Seminar Series has merged with the Cell & Developmental Biology Seminar Series to form a new Basic & Translational Sciences Seminar Series, sponsored by both the Knight Cancer Institute and CBD. Upcoming speakers in September: September 10 at 4 p.m. in room UHS 8B60 – Klaus H. Kaestner, Ph.D., University of Pennsylvania School of Medicine September 24 at 4 p.m. in room UHS 8B60 – Aykut Uren, M.D., Georgetown University Medical … Read More

125th lecture series: Sir Bruce Ponder discusses genes and cancer, July 9

For the next event in the 125th Anniversary Lecture Series, the OHSU School of Medicine in conjunction with the Knight Cancer Institute invite you to a lecture from Sir Bruce Ponder, M.D., Ph.D., FRS, professor of oncology and director, Cancer Research UK Cambridge Research Institute, University of Cambridge. When: July 9, 2013 at 4 p.m. Where: OHSU Hospital, 8th floor auditorium Who: All OHSU faculty, staff and trainees About the lecture Dr. Ponder will update … Read More

New O2 site for cancer researchers

The Knight Cancer Institute has a new presence on OHSU’s intranet, O2. The new site contains information about: Knight Cancer research seminars and events Logos, letterhead and other templates OHSU Knight BioLibrary resources Technology transfer and industry partnerships for cancer researchers Clinical trials office support resources Visit the new Knight Cancer Institute O2 site.

V Foundation cancer research funding, internal deadlines May 17 & 24

The V Foundation for Cancer Research has invited OHSU to submit applications for two of their research programs this cycle: The V Foundation Translational Myelodysplastic Syndromes Research Project Offers up to $400,000 over two years in support of a translational research project on Myelodysplastic Syndromes as it relates to people with or at risk for cancer. Deadlines Internal deadline: May 17, 2013 Letter of Intent: May 31, 2013 Full application (by invitation only): June 19, … Read More

V Foundation cancer research funding, internal deadline April 5

The V Foundation for Cancer Research – Translational Awards provide up to $200,000 per year for three years to fund projects that intend to develop novel, translational approaches to the prevention, detection and treatment of human cancer. Collaboration of investigators from both the lab and clinic is required. Project teams must have a minimum of two scientists from the same facility and the team must possess basic and clinical research expertise. One application is permitted … Read More

Knight Cancer Institute Pilot Project funding, pre-proposals due March 29

The OHSU Knight Cancer Institute is now accepting applications for Pilot Project funding. The purpose of these $50,000 awards is to cultivate outstanding translational cancer research by assisting in the generation of preliminary data leading to peer-reviewed, national funding. This mechanism is intended to support clinical, basic, or population-based research that is cancer focused. Scientific excellence will be the key review element for all applications. Interdisciplinary research, in which investigators from disparate scientific areas collaborate to … Read More

W. M. Keck Foundation to support new microscopy collaboration at OHSU

The OHSU Center for Spatial Systems Biomedicine (OCSSB), a multidisciplinary center within the OHSU Knight Cancer Institute and School of Medicine, has been awarded $1 million by the W. M. Keck Foundation to support the world’s first microscope that integrates both light and electron microscope techniques. This state-of-the-art technology, being developed in collaboration with Hillsboro-based FEI, allows researchers to associate cell behavior to precise points in the cellular architecture. Researchers from around the globe, including OHSU, … Read More

Tomasz Beer, M.D., to join Dream Team for prostate cancer research

OHSU researcher and Knight Cancer Institute Deputy Director Tomasz Beer, M.D., has been selected to participate in a prestigious, six-person Dream Team to fight advanced-stage prostate cancer. Funding for this collaborative initiative is provided by Stand Up to Cancer, the Prostate Cancer Foundation, and the American Association for Cancer Research. Dr. Beer will be working with researchers from four University of California campuses–San Francisco, Los Angeles, Santa Crus, and Davis–as well as the University of … Read More

Welcome to the Research News Blog

Welcome to the Research News Blog

OHSU Research News is your portal to information about all things research at Oregon Health & Science University. Visit often for updates on events, discoveries, and important funding information.

Read more

Participation Guidelines

Remember: information you share here is public; it isn't medical advice. Need advice or treatment? Contact your healthcare provider directly. Read our Terms of Use and this disclaimer for details.

Categories

Archives